KINTOR PHARMA-B(09939),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09939 KINTOR PHARMA-B

Trading 02-09 11:06:07

2.720

+0.090

+3.42%

High2.790	Low2.650	Vol404.00K
Open2.790	D1 Closing2.630	Amplitude5.32%
Mkt Cap1.36B	Tradable Cap1.36B	Total Shares499.00M
T/O1.09M	T/O Rate0.08%	Tradable Shares499.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09939","market":"HK","secType":"STK","nameCN":"KINTOR PHARMA-B","latestPrice":2.72,"timestamp":1770606150026,"preClose":2.63,"halted":0,"volume":404000,"delay":0,"changeRate":0.034220532319391754,"floatShares":499000000,"shares":499000000,"eps":-0.360537,"marketStatus":"Trading","change":0.09,"latestTime":"02-09 11:06:07","open":2.79,"high":2.79,"low":2.65,"amount":1090755,"amplitude":0.053232,"askPrice":2.72,"askSize":4000,"bidPrice":2.7,"bidSize":86000,"shortable":0,"etf":0,"ttmEps":-0.367,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1770609600000},"marketStatusCode":2,"adr":0,"listingDate":1590076800000,"exchange":"SEHK","adjPreClose":2.63,"openAndCloseTimeList":[[1770600600000,1770609600000],[1770613200000,1770624000000]],"volumeRatio":0.705091,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09939/wiki","defaultTab":"wiki","newsList":[{"id":"1144717627","title":"Decoding Investment Clues from Latest Earnings Reports of Pharma Giants","url":"https://stock-news.laohu8.com/highlight/detail?id=1144717627","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144717627?lang=en_us&edition=fundamental","pubTime":"2026-02-09 10:31","pubTimestamp":1770604318,"startTime":"0","endTime":"0","summary":"The recent U.S. stock earnings season coincides with the release of full-year 2025 performance forecasts by some pharmaceutical companies listed in A-shares and Hong Kong stocks. Here is a summary of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1515","BK1574","09939","BK1161"],"gpt_icon":0},{"id":"1119636136","title":"BIOSTAR PHARM-B Receives CSRC Filing Notice for Full Share Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=1119636136","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119636136?lang=en_us&edition=fundamental","pubTime":"2026-02-09 08:32","pubTimestamp":1770597152,"startTime":"0","endTime":"0","summary":"BIOSTAR PHARM-B (02563) announced that the company has received a filing notice issued by the China Securities Regulatory Commission (CSRC) on February 5, 2026. According to the notice, the company...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","02563","BK1574","BK1161","09939","159938"],"gpt_icon":0},{"id":"1143397708","title":"Qinghai Implements Multiple Measures to Promote Traditional Chinese and Tibetan Medicine Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=1143397708","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143397708?lang=en_us&edition=fundamental","pubTime":"2026-02-09 01:50","pubTimestamp":1770573037,"startTime":"0","endTime":"0","summary":"On February 5, it was announced at the 2026 Provincial Traditional Chinese and Tibetan Medicine Work Conference that during the \"14th Five-Year Plan\" period, Qinghai province has continuously...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1161","BK1515","09939","BK1574"],"gpt_icon":0},{"id":"1189658924","title":"BIOSTAR PHARM-B Receives CSRC Filing Notice for Full Circulation of H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1189658924","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189658924?lang=en_us&edition=fundamental","pubTime":"2026-02-06 22:52","pubTimestamp":1770389534,"startTime":"0","endTime":"0","summary":"BIOSTAR PHARM-B (02563) has announced that the company received a filing notice from the China Securities Regulatory Commission (CSRC) dated February 5, 2026. According to the notice, the company has...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","02563","09939","BK1161","BK1515","BK1574"],"gpt_icon":0},{"id":"1114832908","title":"Tasly Pharmaceutical Reports 11.05 Billion Yuan Net Profit for 2025, Marking 15.68% Year-on-Year Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1114832908","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114832908?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:46","pubTimestamp":1770381977,"startTime":"0","endTime":"0","summary":"CHINARES PHARMA (03320) has released the unaudited preliminary financial data for Tasly Pharmaceutical Group Co.,Ltd. for the year ended December 31, 2025. Tasly Pharmaceutical achieved total...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1161","BK0188","BK1191","BK0183","03320","BK0028","BK1515","BK1570","600535","09939","BK0196","BK0239","BK0012","BK1574"],"gpt_icon":0},{"id":"1168835529","title":"TYK MEDICINES-B's New Drug Application for TY-9591 Tablets Accepted by Regulatory Authority","url":"https://stock-news.laohu8.com/highlight/detail?id=1168835529","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168835529?lang=en_us&edition=fundamental","pubTime":"2026-02-06 17:06","pubTimestamp":1770368786,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) has announced that the New Drug Application (NDA) for its investigational Class 1 new drug, TY-9591 tablets (Edotinib Mesylate Tablets), has been accepted for review by the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","09939","TY","BK1515","159938","BK1161","BK1574"],"gpt_icon":0},{"id":"1102746798","title":"TYK MEDICINES-B Shares Surge Nearly 5% in Afternoon Session as Key Drug Gains Priority Review Status","url":"https://stock-news.laohu8.com/highlight/detail?id=1102746798","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102746798?lang=en_us&edition=fundamental","pubTime":"2026-02-06 14:26","pubTimestamp":1770359177,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) experienced a notable increase of nearly 5% during afternoon trading. At the time of writing, the stock was up 3.65%, trading at HK$13.06, with a turnover of HK$28.91 million....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4585","BK1161","09939","BK1515","159938","BK4588","VXUS","VT","02410"],"gpt_icon":0},{"id":"1148112744","title":"Great Wall Fund's Healthcare Investment Team Maintains Optimism on Medical Technology and Seeks New Rationale for Innovative Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1148112744","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148112744?lang=en_us&edition=fundamental","pubTime":"2026-02-05 20:31","pubTimestamp":1770294703,"startTime":"0","endTime":"0","summary":"Following recent market overheating, a phase of consolidation has emerged, primarily driven by expectations of overseas liquidity tightening and pressure from cyclical sector adjustments. Looking...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","06978","BK1515","159891","159938","BK1161","159992","BK1574"],"gpt_icon":0},{"id":"1132125759","title":"BOCOM International Forecasts Continued Stable Growth for Healthcare Sector This Year, Recommends Seeking Undervalued Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1132125759","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132125759?lang=en_us&edition=fundamental","pubTime":"2026-02-05 17:16","pubTimestamp":1770282992,"startTime":"0","endTime":"0","summary":"The Hang Seng Healthcare Index declined 3.3% this week, underperforming the broader market. Since the fourth quarter of last year, the proportion of mainland capital holding pharmaceutical stocks...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","SG9999014674.SGD","03329","BK1593","BK1587","BK1583","BK1147","BK1161","00013","BK1574","LU2488822045.USD","02595","BK1191","BK1515","159938","02268","BK1588","09939","BK1141","HK0000165453.HKD"],"gpt_icon":0},{"id":"1193261398","title":"Healthcare Sector Demonstrates Resilience as Traditional Chinese Medicine Leaders Lead Gains, While Exclusive Pharmaceutical ETF Defies Market Downturn","url":"https://stock-news.laohu8.com/highlight/detail?id=1193261398","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193261398?lang=en_us&edition=fundamental","pubTime":"2026-02-05 11:33","pubTimestamp":1770262421,"startTime":"0","endTime":"0","summary":"On February 5th, the A-share market opened lower and continued its decline, undergoing a significant correction, while the healthcare sector bucked the trend to trade higher, showcasing its...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["512170","BK1574","BK1515","09939","BK1161","159938","159828","562050"],"gpt_icon":0},{"id":"1181461711","title":"OpenAI Explores New Revenue Streams in Pharma: Plans \"Investment Plus Royalty\" Model to Target AI-Driven Biotech Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=1181461711","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181461711?lang=en_us&edition=fundamental","pubTime":"2026-02-04 10:40","pubTimestamp":1770172801,"startTime":"0","endTime":"0","summary":"According to information obtained by Zhitong Finance APP, OpenAI CEO Sam Altman indicated that the company is considering investing in or subsidizing firms that heavily utilize its artificial...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09939","BK1574","BK1515","159938"],"gpt_icon":0},{"id":"1102586398","title":"32 New Funds Launched This Week: 27 Firms Including GF and E Fund Compete Across Battery, AI, Healthcare, and Gold Sectors, Some Products Already Closed Early","url":"https://stock-news.laohu8.com/highlight/detail?id=1102586398","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102586398?lang=en_us&edition=fundamental","pubTime":"2026-02-03 19:41","pubTimestamp":1770118891,"startTime":"0","endTime":"0","summary":"This week, the new fund market witnessed a minor issuance peak, with a total of 32 new products opening for subscription. These involve 27 fund companies, including GF Fund, E Fund, Southern Asset...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","NUGT","MGCmain","159796","QOmain","518880","IAU","GDX","SGCmain","159934","BK4588","159831","GLD","BK4535","BK1574","BK1515","BK4585","SGUmain","UGL","DUST","BK4504","159938","GCmain","GLDM","1OZmain","09939"],"gpt_icon":1},{"id":"1192368771","title":"Hubei Jumpcan Pharmaceutical (600566.SZ) Subsidiary Signs Exclusive Commercialization Agreement with Puqi Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=1192368771","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192368771?lang=en_us&edition=fundamental","pubTime":"2026-02-02 18:35","pubTimestamp":1770028508,"startTime":"0","endTime":"0","summary":"Hubei Jumpcan Pharmaceutical Co.,Ltd. (600566.SZ) announced that its wholly-owned subsidiary, Jichuan Pharmaceutical Group Co., Ltd. (\"Jichuan Limited\"), has entered into an exclusive...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600566","09939","BK0187","BK1574","BK1161","BK1515","159938","BK0188","BK0239","BK0028","BK0077","BK0012","BK0201"],"gpt_icon":0},{"id":"1141737931","title":"KINTOR PHARMACEUTICAL LIMITED (09939) Announces Monthly Return as of January 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1141737931","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141737931?lang=en_us&edition=fundamental","pubTime":"2026-02-02 17:24","pubTimestamp":1770024291,"startTime":"0","endTime":"0","summary":"KINTOR PHARMACEUTICAL LIMITED disclosed its monthly return for equity securities on The Stock Exchange of Hong Kong Limited for the period ended January 31, 2026. According to the announcement, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939"],"gpt_icon":0},{"id":"1193491872","title":"283 Healthcare Stocks Preview 2025 Performance: Top Forecast Shows Over 32-Fold Increase, 39 Stocks Including Zhifei Biological Report First Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1193491872","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193491872?lang=en_us&edition=fundamental","pubTime":"2026-02-01 21:42","pubTimestamp":1769953377,"startTime":"0","endTime":"0","summary":"The 2025 performance outlook for A-share healthcare stocks presents a mixed picture. Data shows that as of February 1, a total of 283 healthcare stocks have provided preliminary insights into their...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","LU2580892862.HKD","LU1064130708.USD","09939","BK0077","BK1515","LU1064131003.USD","BK0196","BK1574","LU2580892789.USD","BK0046","300122","LU1328615791.USD","BK1161","BK0239","159938","LU2148510915.USD"],"gpt_icon":0},{"id":"1186833842","title":"New Stock Alert | Xinji Pharmaceutical, Yifei Technology Among Companies With Hong Kong IPO Applications Accepted by China Securities Regulatory Commission","url":"https://stock-news.laohu8.com/highlight/detail?id=1186833842","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186833842?lang=en_us&edition=fundamental","pubTime":"2026-01-30 20:34","pubTimestamp":1769776456,"startTime":"0","endTime":"0","summary":"According to information obtained by Zhitong Caijing APP, on January 30, the China Securities Regulatory Commission (CSRC) released the \"Status Table for Overseas Securities Issuance and Listing by...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK1515","BK1574","BK1161","09939","159938"],"gpt_icon":0},{"id":"1148709850","title":"Yan'an Pharma's Second Attempt at BSE Listing: Strained Cash Flow, Persistent Margin Pressure, and Governance Concerns Draw Regulatory Scrutiny","url":"https://stock-news.laohu8.com/highlight/detail?id=1148709850","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148709850?lang=en_us&edition=fundamental","pubTime":"2026-01-30 15:06","pubTimestamp":1769756780,"startTime":"0","endTime":"0","summary":"Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd. (hereinafter referred to as \"Yan'an Pharma\") has once again submitted a listing application to the Beijing Stock Exchange, with Tianfeng Securities...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1515","BK1161","159399","BK1574","159938"],"gpt_icon":0},{"id":"1114485393","title":"Renfu Pharmaceutical Claim Submission Filed for Registration, Eligible Investors Can Register","url":"https://stock-news.laohu8.com/highlight/detail?id=1114485393","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114485393?lang=en_us&edition=fundamental","pubTime":"2026-01-30 14:09","pubTimestamp":1769753374,"startTime":"0","endTime":"0","summary":"Affected investors can register their claims on the Sina Investor Rights Protection platform. Pay attention to @Sina Securities, follow Sina Brokerage Fund on WeChat, search for Sina Investor Rights...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1161","BK1515","09939","BK1574"],"gpt_icon":0},{"id":"1199886224","title":"Hong Kong Stock Movement | TYK MEDICINES-B (02410) Surges Over 13% in Morning Session as Aimdotinib Mesylate Tablets Included in Priority Review List","url":"https://stock-news.laohu8.com/highlight/detail?id=1199886224","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199886224?lang=en_us&edition=fundamental","pubTime":"2026-01-30 09:52","pubTimestamp":1769737939,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) surged more than 13% during the morning session. As of the time of writing, the stock was up 8.94%, trading at HK$13.52, with a turnover of HK$40.70 million. The company...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","09939","BK4585","BK1515","159938","BK4588","BK1161","BK1574","VT"],"gpt_icon":0},{"id":"1181975144","title":"TYK MEDICINES-B (02410) Has Its Investigational Class 1 New Drug, Aidosertinib Mesylate Tablets, Included in the CDE's Priority Review List","url":"https://stock-news.laohu8.com/highlight/detail?id=1181975144","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181975144?lang=en_us&edition=fundamental","pubTime":"2026-01-29 17:10","pubTimestamp":1769677818,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) announced that its investigational Class 1 new drug, Aidosertinib Mesylate Tablets (TY-9591 tablets), has been included in the Priority Review品种 list by the Center for Drug...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","159938","09939","BK1515","02410","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kintor.com.cn","stockEarnings":[{"period":"1week","weight":-0.0674},{"period":"1month","weight":0.2406},{"period":"3month","weight":0.538},{"period":"6month","weight":0.2705},{"period":"1year","weight":1.9551},{"period":"ytd","weight":0.3418}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0121},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.2713},{"period":"ytd","weight":0.0363}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Kintor Pharmaceutical Ltd is an investment holding company primarily engaged in the research and development of innovative medicine products. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.020286},{"month":2,"riseRate":0.666667,"avgChangeRate":0.172028},{"month":3,"riseRate":0.4,"avgChangeRate":0.084454},{"month":4,"riseRate":0.6,"avgChangeRate":0.421119},{"month":5,"riseRate":0.6,"avgChangeRate":0.045244},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.066873},{"month":7,"riseRate":0.666667,"avgChangeRate":0.132768},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.071497},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.129033},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.103242},{"month":11,"riseRate":0.666667,"avgChangeRate":0.073526},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.185801}],"exchange":"SEHK","name":"KINTOR PHARMA-B","nameEN":"KINTOR PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"KINTOR PHARMA-B(09939),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest KINTOR PHARMA-B(09939) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"KINTOR PHARMA-B,09939,KINTOR PHARMA-B股票,KINTOR PHARMA-B股票老虎,KINTOR PHARMA-B股票老虎国际,KINTOR PHARMA-B行情,KINTOR PHARMA-B股票行情,KINTOR PHARMA-B股价,KINTOR PHARMA-B股市,KINTOR PHARMA-B股票价格,KINTOR PHARMA-B股票交易,KINTOR PHARMA-B股票购买,KINTOR PHARMA-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"KINTOR PHARMA-B(09939),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest KINTOR PHARMA-B(09939) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}